Nastassia Samal
Peak Pharmaceuticals (OTCPK:PKPH) has merged with software company Retrieve Medical and plans to change its name to Retrieve Medical Holdings Inc.
Retrieve sells a Clinical Documentation Improvement (CDI) platform called Retrieve Dx. The software helps physicians understand clinical history of patients and diagnose chronic conditions by analyzing physician notes, lab results and EKG interpretations, among other things, according to the companies.
Peak acquired all outstanding capital stock of Retrieve in exchange for issuing to Retrieve's shareholders ~16.34M Peak common stock, representing ~86% of its issued and outstanding shares.
Retrieve Shareholders have become the majority shareholders of the company.
Peak's sole Director Neil Reithinger approved the transactions and resigned as CEO CFO and director.
Peak noted that it has now ceased being a shell company.
As of March 27, the closing date of the transaction, Retrieve's CEO Jerry Swon was appointed as CEO of the combined company.
"After years of product development, a successful proof of concept program with a prominent hospital in New York, and validation by the 2 largest EMRs in the world, Retrieve is now ready to expand its patented software offering to hospitals and other healthcare providers across the United States," said Swon.
The company plans to take steps to change its name to Retrieve Medical Holdings Inc; its trading symbol; and its fiscal year end from Sept. 30 to Dec. 31.